Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1999;33:856-861

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chillon, J.-M.
Right arrow Articles by Baumbach, G. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chillon, J.-M.
Right arrow Articles by Baumbach, G. L.
Related Collections
Right arrow Cerebrovascular disease/stroke
Right arrow Cardiovascular Pharmacology
Right arrow Animal models of human disease
Right arrow Hypertension - basic studies

(Hypertension. 1999;33:856-861.)
© 1999 American Heart Association, Inc.


Scientific Contributions

Effects of an Angiotensin-Converting Enzyme Inhibitor and a ß-Blocker on Cerebral Arterioles in Rats

Jean-Marc Chillon; Gary L. Baumbach

From the Department of Pathology, University of Iowa College of Medicine and Cardiovascular Center, Iowa City, Iowa.

Correspondence to Gary L. Baumbach, MD, Department of Pathology, 5232-A RCP, 100 Medical Laboratories, University of Iowa College of Medicine, Iowa City, IA 52242. E-mail g-baumbach{at}uiowa.edu

Abstract—We examined the effects of an angiotensin-converting enzyme inhibitor, perindopril, and a ß-blocker, propranolol, on cerebral arterioles in stroke-prone spontaneously hypertensive rats (SHRSP). The structure and mechanics of cerebral arterioles were examined in untreated Wistar-Kyoto rats (WKY) and SHRSP that were untreated or treated for 3 months with a high (2 mg/kg per day) or a low (0.3 mg/kg per day) dose of perindopril or propranolol (250 mg/kg per day) alone or in combination with the low dose of perindopril. We measured pressure, external diameter, and cross-sectional area of the vessel wall (CSA) in maximally dilated (with EDTA) cerebral arterioles. Treatment of SHRSP with the high dose of perindopril or the combination of propranolol and the low dose of perindopril normalized cerebral arteriolar mean pressure (50±1 [mean±SEM] and 43±2 mm Hg vs 50±1 mm Hg in WKY and 94±3 mm Hg in untreated SHRSP; P<0.05), pulse pressure (15±1 and 16±1 mm Hg vs 13±1 mm Hg in WKY and 35±1 mm Hg in untreated SHRSP; P<0.05), and CSA (1103±53 and 1099±51 µm2, respectively, vs 1057±49 µm2 in WKY and 1281±62 µm2 in untreated SHRSP; P<0.05). In contrast, treatment of SHRSP with the low dose of perindopril or propranolol alone did not normalize arteriolar pulse pressure (24±1 and 21±1 mm Hg) and failed to prevent increases in CSA (1282±77 and 1267±94 µm2). Treatment with either dose of perindopril or the combination of propranolol and perindopril significantly increased external diameter in cerebral arterioles of SHRSP (99±3, 103±2, and 98±3 µm vs 87±2 µm in untreated SHRSP; P<0.05), whereas propranolol alone did not (94±3 µm; P>0.05). These findings suggest that effects of angiotensin-converting enzyme inhibitors on cerebral arteriolar hypertrophy in SHRSP may depend primarily on their effects on arterial pressure, particularly pulse pressure, whereas their effects on cerebral arteriolar remodeling (defined as a reduction in external diameter) may be pressure independent.


Key Words: hypertension, chronic • vascular remodeling • angiotensin • hypertrophy, vascular




This article has been cited by other articles:


Home page
HypertensionHome page
J. R. Jennings, M. F. Muldoon, J. Price, I. C. Christie, and C. C. Meltzer
Cerebrovascular Support for Cognitive Processing in Hypertensive Patients Is Altered by Blood Pressure Treatment
Hypertension, July 1, 2008; 52(1): 65 - 71.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. J. Cipolla, J. Smith, N. Bishop, L. V. Bullinger, and J. A. Godfrey
Pregnancy Reverses Hypertensive Remodeling of Cerebral Arteries
Hypertension, April 1, 2008; 51(4): 1052 - 1057.
[Abstract] [Full Text] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
G. Zuliani, A. Cherubini, S. Volpato, A. R. Atti, A. Ble, C. Vavalle, F. Di Todaro, C. Benedetti, C. Ruggiero, U. Senin, et al.
Treatment With Angiotensin-Converting Enzyme Inhibitors Is Associated With a Reduction in Short-Term Mortality in Older Patients With Acute Ischemic Stroke
J. Gerontol. A Biol. Sci. Med. Sci., April 1, 2005; 60(4): 463 - 465.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J.-M. Chillon and G. L. Baumbach
Effects of Indapamide, a Thiazide-Like Diuretic, on Structure of Cerebral Arterioles in Hypertensive Rats
Hypertension, May 1, 2004; 43(5): 1092 - 1097.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. L. Baumbach, C. D. Sigmund, and F. M. Faraci
Cerebral Arteriolar Structure in Mice Overexpressing Human Renin and Angiotensinogen
Hypertension, January 1, 2003; 41(1): 50 - 55.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
B.I. Levy, G. Ambrosio, A.R. Pries, and H.A.J. Struijker-Boudier
Microcirculation in Hypertension: A New Target for Treatment?
Circulation, August 1, 2001; 104(6): 735 - 740.
[Full Text] [PDF]


Home page
HypertensionHome page
J.-M. Chillon and G. L. Baumbach
Effects of an Angiotensin-Converting Enzyme Inhibitor and a {beta}-Blocker on Cerebral Arteriolar Dilatation in Hypertensive Rats
Hypertension, June 1, 2001; 37(6): 1388 - 1393.
[Abstract] [Full Text] [PDF]